What Flinn.ai does
Flinn.ai sells an AI platform that automates quality and regulatory processes for medical device and IVD manufacturers, including post-market surveillance, literature evaluation, complaint handling and safety-database monitoring across more than 15 databases. The company says more than 200 global MedTech and IVD companies use the platform, from small manufacturers to large corporations managing thousands of technical files. Flinn.ai was co-founded in 2022 by Bastian Krapinger-Rüther, Markus Müller and Hasib Samad and is based in Vienna.
Flinn.ai is a healthcare tool on Falcoscan. AI platform that automates regulatory compliance for medical device makers. Falcoscan rates Flinn.ai with an Opportunity score of 84/100, a Saturation score of 11/100, and a Wrapper-risk score of 9/100. Market signal: rising. Flinn.ai is founded in 2022, currently at Series_a stage. Pricing: Paid.